Abstract
Background
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, leading to kidney failure. One of the most serious extrarenal complications of ADPKD is comorbid intracranial aneurysms. The aim of this study is to evaluate the prevalence, rupture rate, and treatment outcomes of intracranial aneurysms in ADPKD.
Methods
Adult patients with a documented diagnosis of ADPKD who received kidney transplantation at our center from January 1994 to December 2018 were included in the study. Medical history, physical examination, laboratory findings, imaging studies, and operation records were collected and analyzed from our database.
Results
Among 154 kidney transplant recipients with ADPKD, 113 (73.4%) patients were screened for intracranial aneurysms preoperatively. Twenty three patients (14.9%) had intracranial aneurysms with mean diameter size of 4.5 ± 2.7 mm. Nine patients (5.8%) experienced aneurysm rupture and the mean age at time of rupture was 34.9 ± 9.3 years. Twelve patients (52.2%) presented with multiple aneurysms. The most common aneurysm location was the bifurcation of the middle cerebral artery (34.9%). Clipping was the most common treatment in both ruptured and unruptured aneurysms.
Conclusions
Intracranial aneurysms are more frequent in patients with ADPKD, and the average age of intracranial artery rupture in patients with ADPKD is earlier than in the general population. It is necessary to consider proper evaluation and management of intracranial aneurysms when counseling ADPKD patients who will undergo kidney transplantation.
Similar content being viewed by others
References
Aboualaiwi WA, Muntean BS, Ratnam S, Joe B, Liu L, Booth RL, Rodriguez I, Herbert BS, Bacallao RL, Fruttiger M, Mak TW, Zhou J, Nauli SM (2014) Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation. Circulation 129:660–672. https://doi.org/10.1161/CIRCULATIONAHA.113.005746
Bichet D, Peters D, Patel AJ, Delmas P, Honore E (2006) Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models. Trends Cardiovasc Med 16:292–298. https://doi.org/10.1016/j.tcm.2006.07.002
Cagnazzo F, Gambacciani C, Morganti R, Perrini P (2017) Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review. Acta Neurochir 159:811–821. https://doi.org/10.1007/s00701-017-3142-z
Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grunfeld JP (1994) Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 45:1140–1146
Cho BH, Kim JH, Suh SH, Baik SJ, Lee HS, Kim J, Lee KY (2019) Characteristics of intracranial aneurysms according to levels of coronary artery calcium. Stroke 50:1403–1408. https://doi.org/10.1161/STROKEAHA.119.024726
Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2012) United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis : Off J Natl Kidney Found 59:A7, e1–A7,420. https://doi.org/10.1053/j.ajkd.2011.11.015
Ecder T, Schrier RW (2009) Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 5:221–228. https://doi.org/10.1038/nrneph.2009.13
Foroud T, Sauerbeck L, Brown R, Anderson C, Woo D, Kleindorfer D, Flaherty ML, Deka R, Hornung R, Meissner I, Bailey-Wilson JE, Langefeld C, Rouleau G, Connolly ES, Lai D, Koller DL, Huston J, 3rd, Broderick JP, Familial Intracranial Aneurysm Study I (2009) Genome screen in familial intracranial aneurysm. BMC Med Genet 10:3. https://doi.org/10.1186/1471-2350-10-3
Harada H, Furuya M, Ishikura H, Shindo J, Koyanagi T, Yoshiki T (2002) Expression of matrix metalloproteinase in the fluids of renal cystic lesions. J Urol 168:19–22
Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thone-Reineke C, Braun N, Neumayer HH, Koppenhagen K, Bauer C, Rohmeiss P (1998) Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol : JASN 9:1169–1177
Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC (1995) The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10:151–160. https://doi.org/10.1038/ng0695-151
Huston J 3rd, Torres VE, Sulivan PP, Offord KP, Wiebers DO (1993) Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol : JASN 3:1871–1877
Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT (1983) Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis: Off J Natl Kidney Found 2:630–639
Irazabal MV, Huston J 3rd, Kubly V, Rossetti S, Sundsbak JL, Hogan MC, Harris PC, Brown RD Jr, Torres VE (2011) Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol : CJASN 6:1274–1285. https://doi.org/10.2215/CJN.09731110
Kim T, Lee H, Ahn S, Kwon OK, Bang JS, Hwang G, Kim JE, Kang HS, Son YJ, Cho WS, Oh CW (2016) Incidence and risk factors of intracranial aneurysm: a national cohort study in Korea. Int J Stroke: Off J Int Stroke Soc 11:917–927. https://doi.org/10.1177/1747493016660096
Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T (2004) Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis : Off J Natl Kidney Found 43:854–860
Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339–1342
Morel N, Vandenberg G, Ahrabi AK, Caron N, Desjardins F, Balligand JL, Horie S, Devuyst O (2009) PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Arch Eur J Physiol 457:845–856. https://doi.org/10.1007/s00424-008-0561-y
Nakajima F, Shibahara N, Arai M, Gohji K, Ueda H, Katsuoka Y (2000) Intracranial aneurysms and autosomal dominant polycystic kidney disease: follow-up study by magnetic resonance angiography. J Urol 164:311–313
Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33:129–137. https://doi.org/10.1038/ng1076
Nauli SM, Kawanabe Y, Kaminski JJ, Pearce WJ, Ingber DE, Zhou J (2008) Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 117:1161–1171. https://doi.org/10.1161/CIRCULATIONAHA.107.710111
Perrone RD, Malek AM, Watnick T (2015) Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 11:589–598. https://doi.org/10.1038/nrneph.2015.128
Qian Q, Hunter LW, Du H, Ren Q, Han Y, Sieck GC (2007) Pkd2+/− vascular smooth muscles develop exaggerated vasocontraction in response to phenylephrine stimulation. J Am Soc Nephrol 18:485–493. https://doi.org/10.1681/ASN.2006050501
Rankin CA, Suzuki K, Itoh Y, Ziemer DM, Grantham JJ, Calvet JP, Nagase H (1996) Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules. Kidney Int 50:835–844
Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC (2003) Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361:2196–2201. https://doi.org/10.1016/S0140-6736(03)13773-7
Schievink WI, Torres VE, Piepgras DG, Wiebers DO (1992) Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:88–95
Schrier RW, Belz MM, Johnson AM, Kaehny WD, Hughes RL, Rubinstein D, Gabow PA (2004) Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. J Am Soc Nephrol 15:1023–1028
Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287–1301. https://doi.org/10.1016/S0140-6736(07)60601-1
Vlak MH, Algra A, Brandenburg R, Rinkel GJ (2011) Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 10:626–636. https://doi.org/10.1016/S1474-4422(11)70109-0
Wang D, Iversen J, Wilcox CS, Strandgaard S (2003) Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 64:1381–1388. https://doi.org/10.1046/j.1523-1755.2003.00236.x
Xu HW, Yu SQ, Mei CL, Li MH (2011) Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 42:204–206. https://doi.org/10.1161/STROKEAHA.110.578740
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. This study received approval from the institutional review board of Asan Medical Center (approval number: 2019-0310).
For this type of study, formal consent is not required.
Additional information
Comments
Special high-risk subgroups are always interesting when we look for patients who will benefit from screening and treatment of UIA. This paper adds to our knowledge of the demographics and risk associated with UIA in polycystic kidney disease, ADPKD.
The authors screened with CTA, MRA, or DSA (over a 24 year period) 113 ADPKD patients for intracranial aneurysms prior to scheduled kidney transplantation. Twenty three patients (14.9%) had intracranial aneurysms with mean diameter size of 4.5 ± 2.7 mm. Nine patients (5.8%) experienced aneurysm rupture and the mean age at time of rupture was 34.9 ± 9.3 years. Twelve patients (52.2%) presented with multiple aneurysms. The most common aneurysm location was the bifurcation of the middle cerebral artery (34.9%). More than half of these patients had multiple aneurysms.
Clipping was the most common treatment in both ruptured and unruptured aneurysms, probably because of the years in which the study was done. We do not have data on clipping or endovascular treatment either before or after transplantation, nor what algorithms were used to recommend treatment.
The authors conclude that intracranial aneurysms are more frequent in patients with ADPKD and, important to consider, that the average age of intracranial artery rupture in patients with ADPKD is earlier than in the general population.
In considering this article we would ask the following further questions, with a recommendation that some of these unanswered questions form the basis for future study:
1. Is the rupture rate higher than the general UIA population? Apparently not, although rupture appears to occur at a younger age.
2. Is there a risk to performing transplant with an untreated UIA? Should aneurysms be treated before the renal transplant is done? Not discussed in this article.
3. What size are the ruptured aneurysms? Not discussed in this article.
4. What is the risk of UIA treatment in their group? Not discussed in this article.
In my personal experience unruptured aneurysm surgery in patients on dialysis has a higher risk profile, because of postoperative fluid shifts and the potential for brain edema, than in patients with normal renal function. This is a natural question for these authors to consider in future.
In my opinion this is a good article and I believe we can learn from a further analysis of this compelling group of patients.
Christopher Loftus
PA, USA
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Vascular Neurosurgery - Aneurysm
Rights and permissions
About this article
Cite this article
Kim, J.Y., Jung, S.C., Ko, Y. et al. Intracranial aneurysms in patients receiving kidney transplantation for autosomal dominant polycystic kidney disease. Acta Neurochir 161, 2389–2396 (2019). https://doi.org/10.1007/s00701-019-04060-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-019-04060-7